X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (35926) 35926
Publication (5134) 5134
Newsletter (1018) 1018
Book Chapter (382) 382
Book Review (360) 360
Book / eBook (200) 200
Newspaper Article (177) 177
Dissertation (104) 104
Conference Proceeding (102) 102
Magazine Article (78) 78
Government Document (33) 33
Reference (31) 31
Transcript (30) 30
Web Resource (14) 14
Data Set (10) 10
Trade Publication Article (9) 9
Report (7) 7
Journal / eJournal (4) 4
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (20688) 20688
humans (16141) 16141
index medicus (16141) 16141
mice (11119) 11119
immunology (10904) 10904
female (8595) 8595
vaccines (7584) 7584
proteins (7307) 7307
recombinant proteins (6027) 6027
recombinant proteins - immunology (5973) 5973
immunization (5361) 5361
microbiology (5266) 5266
recombinant (5232) 5232
vaccination (5218) 5218
antigens (5046) 5046
recombinant proteins - genetics (4910) 4910
biotechnology & applied microbiology (4745) 4745
mice, inbred balb c (4722) 4722
molecular sequence data (4709) 4709
antibodies (4609) 4609
infectious diseases (4423) 4423
virology (4396) 4396
amino acid sequence (4275) 4275
vaccine (4272) 4272
male (4182) 4182
infection (4045) 4045
expression (3943) 3943
viruses (3840) 3840
recombinant fusion proteins - immunology (3738) 3738
medicine, research & experimental (3709) 3709
analysis (3674) 3674
gene expression (3673) 3673
health aspects (3629) 3629
research (3613) 3613
enzyme-linked immunosorbent assay (3420) 3420
biochemistry & molecular biology (3328) 3328
recombinant fusion proteins - genetics (3247) 3247
research article (3202) 3202
immunogenicity (3064) 3064
recombinant proteins - metabolism (2888) 2888
infections (2847) 2847
vaccines, synthetic - immunology (2788) 2788
cell line (2745) 2745
immune response (2729) 2729
cloning, molecular (2585) 2585
genetic vectors (2536) 2536
medicine (2491) 2491
base sequence (2464) 2464
immunity (2441) 2441
multidisciplinary sciences (2431) 2431
protein (2421) 2421
immunotherapy (2344) 2344
veterinary sciences (2340) 2340
escherichia-coli (2315) 2315
biotechnology (2263) 2263
adult (2223) 2223
escherichia coli - genetics (2159) 2159
identification (2142) 2142
recombinant proteins - biosynthesis (2056) 2056
parasitology (2029) 2029
science (2022) 2022
mice, inbred c57bl (1986) 1986
antigen (1921) 1921
immune-responses (1915) 1915
virus diseases (1898) 1898
dendritic cells (1879) 1879
recombinant proteins - chemistry (1852) 1852
dna (1829) 1829
antibodies, viral - blood (1816) 1816
medical research (1794) 1794
cancer (1789) 1789
article (1773) 1773
peptides (1765) 1765
cloning (1760) 1760
cells (1756) 1756
oncology (1713) 1713
biology (1703) 1703
gene (1648) 1648
genes (1622) 1622
t cells (1621) 1621
recombinant fusion proteins - metabolism (1578) 1578
genetic aspects (1558) 1558
plasmids (1555) 1555
viral vaccines - immunology (1537) 1537
biochemical research methods (1530) 1530
genetic engineering (1528) 1528
in-vivo (1514) 1514
antigens, bacterial - immunology (1512) 1512
lymphocytes (1488) 1488
escherichia coli (1487) 1487
allergy and immunology (1485) 1485
middle aged (1483) 1483
protection (1483) 1483
life sciences (1473) 1473
physiological aspects (1459) 1459
cell biology (1458) 1458
bacteria (1454) 1454
t-lymphocytes - immunology (1453) 1453
monoclonal-antibodies (1450) 1450
cattle (1440) 1440
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (108) 108
UofT at Mississauga - Stacks (42) 42
Engineering & Comp. Sci. - Stacks (25) 25
UTL at Downsview - May be requested (25) 25
UofT at Scarborough - Stacks (25) 25
Online Resources - Online (12) 12
St. Michael's College (John M. Kelly) - 2nd Floor (12) 12
St. Augustine's Seminary - Stacks (10) 10
Collection Dvlpm't (Acquisitions) - Vendor file (9) 9
Robarts - Stacks (9) 9
Law (Bora Laskin) - Stacks (8) 8
Collection Dvlpm't (Acquisitions) - Closed Orders (7) 7
Regis College - Stacks (6) 6
Earth Sciences (Noranda) - Stacks (3) 3
Victoria University E.J. Pratt - Stacks (3) 3
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Trinity College (John W Graham) - Stacks (2) 2
Trinity College (John W Graham) - Wycliffe Storage (2) 2
Victoria University Emmanuel College - Stacks (2) 2
Baycrest Hospital - Stacks (1) 1
Chemistry (A D Allen) - Stacks (1) 1
Gerstein Science - Searching (1) 1
New College (Ivey) - Stacks (1) 1
OISE - Missing (1) 1
OISE - Stacks (1) 1
Physics - Missing (1) 1
Physics - Stacks (1) 1
St. Michael's Hospital - Stacks (1) 1
UofT at Mississauga - Not Returned (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (36680) 36680
Chinese (559) 559
Russian (125) 125
French (113) 113
German (70) 70
Spanish (66) 66
Portuguese (64) 64
Japanese (42) 42
Korean (32) 32
Polish (30) 30
Persian (13) 13
Italian (10) 10
Dutch (9) 9
Turkish (7) 7
Swedish (6) 6
Czech (5) 5
Danish (5) 5
Hungarian (4) 4
Slovak (3) 3
Bulgarian (2) 2
Norwegian (2) 2
Slovenian (2) 2
Ukrainian (2) 2
Arabic (1) 1
Finnish (1) 1
Hebrew (1) 1
Lithuanian (1) 1
Romanian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Human Vaccines & Immunotherapeutics, ISSN 2164-5515, 07/2015, Volume 11, Issue 7, pp. 1689 - 1702
This observer-blind study (clinicaltrials.gov NCT01462357) compared the immunogenicity and safety of 2 doses of the HPV-16/18 AS04-adjuvanted vaccine... 
y, year(s) | AAHS, aluminum hydroxyphosphate sulfate | CI, confidence interval | PBMC, peripheral blood mononuclear cells | ELISA, enzyme-linked immunosorbent assay | M, month(s) | ELISPOT, enzyme-linked immunosorbent spot assay | human papillomavirus (HPV) vaccines | HPV-6/11/16/18(3D), 3-dose schedule of the HPV-6/11/16/18 vaccine | safety | ANOVA, analysis of variance | female adolescents | 50 | PBNA, pseudovirion-based neutralisation assay | GMT, geometric mean antibody titer | ED | 2D, 2-dose | AS04, Adjuvant System containing 50 µg 3-O-desacyl-4 ′-monophosphoryl lipid A (MPL) adsorbed on aluminum salt (500 µg Al | CMI, cell-mediated immunity | 3D, 3-dose | ) | SAE, serious adverse event | immunogenicity | HPV, human papillomavirus | IgG, immunoglobulin G | TVC, total vaccinated cohort | 3 | ATP-I, according-to-protocol immunogenicity cohort | effective dose producing 50% response | HPV-16/18(2D), 2-dose schedule of the HPV-16/18 vaccine | IFNγ, interferon | VLP, virus-like particle | administration schedule | GMR, geometric mean titer ratio | EU, ELISA unit | HPV-6/11/16/18(2D), 2-dose schedule of the HPV-6/11/16/18 vaccine | pIMD, potential immune-mediated disease | Administration schedule | Safety | Immunogenicity | Human papillomavirus (HPV) vaccines | Female adolescents | PBNA | TVC | enzyme-linked immunosorbent spot assay | pIMD | CLINICAL-TRIAL | potential immune-mediated disease | OF-STUDY ANALYSIS | ELISA unit | IMMUNOLOGY | NEUTRALIZATION ASSAY | 18(3D) | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | geometric mean antibody titer | BLIND PATRICIA TRIAL | CMI | 2-dose | pseudovirion-based neutralisation assay | AS04 | CERVICAL-CANCER | GMR | PBMC | GMT | MEMORY B-CELLS | according-to-protocol immunogenicity cohort | AAHS | PARTICLE VACCINE | SAE | human papillomavirus | HPV VACCINE | ELISA | ATP-I | month(s) | virus-like particle | 3-dose | geometric mean titer ratio | IgG | 2-dose schedule of the HPV-16 | HPV | 18 vaccine | IFN | 18(2D) | CD154 EXPRESSION | analysis of variance | ANOVA | serious adverse event | total vaccinated cohort | year(s) | ED50 | VLP | YOUNG-WOMEN | Adjuvant System containing 50 mu g 3-O-desacyl-4-monophosphoryl lipid A (MPL) adsorbed on aluminum salt (500 mu g Al3+) | peripheral blood mononuclear cells | aluminum hydroxyphosphate sulfate | immunoglobulin G | 3-dose schedule of the HPV-6 | HPV-16 | HPV-6 | 2-dose schedule of the HPV-6 | interferon | ELISPOT | enzyme-linked immunosorbent assay | confidence interval | cell-mediated immunity | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 - adverse effects | Adjuvants, Immunologic - administration & dosage | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 - immunology | Vaccine Potency | Humans | Alphapapillomavirus - immunology | Antibodies, Viral - blood | Immunity, Humoral | Time Factors | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 - administration & dosage | Papillomavirus Infections - prevention & control | Adolescent | Papillomavirus Vaccines - adverse effects | Female | Immunization Schedule | Papillomavirus Vaccines - immunology | Child | Immunity, Cellular | Papillomavirus Vaccines - administration & dosage | Antibodies, Neutralizing - blood | Medical and Health Sciences | Basic Medicine | Medicinsk bioteknologi | Medical Biotechnology | Medicin och hälsovetenskap | Immunologi inom det medicinska området | Immunology in the medical area | Medical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy) | Medicinsk bioteknologi (med inriktning mot cellbiologi (inklusive stamcellsbiologi), molekylärbiologi, mikrobiologi, biokemi eller biofarmaci) | Medicinska och farmaceutiska grundvetenskaper
Journal Article
Human Vaccines, ISSN 1554-8600, 12/2011, Volume 7, Issue 12, pp. 1343 - 1358
Journal Article
Vaccine, ISSN 0264-410X, 2012, Volume 30, Issue 27, pp. 4007 - 4016
Highlights ► Inactivated whole viral (IWV) vaccines conferred good protection against IPN. ► Nanoparticle, sub-unit recombinant vaccines and DNA vaccine are... 
Allergy and Immunology | Inactivated whole virus | Vaccine | IPNV | PLGA nanoparticles | Strain | Recombinant | MEDICINE, RESEARCH & EXPERIMENTAL | STRUCTURAL PROTEIN VP2 | PARTICLES | PROTECTION | PERSISTENCE | SP SEROTYPE | IMMUNOLOGY | VIRULENCE | FORMULATION | NANOPARTICLES | RESPONSES | IMMUNOHISTOCHEMISTRY | Vaccines, DNA - genetics | Vaccines, Subunit - genetics | Viral Vaccines - genetics | Vaccines, DNA - immunology | Drug Carriers - administration & dosage | Vaccines, Synthetic - immunology | Antibodies, Viral - blood | Vaccines, DNA - administration & dosage | Vaccination - methods | Bacterial Toxins - genetics | Vaccines, Inactivated - genetics | Birnaviridae Infections - prevention & control | Salmo salar | Vaccines, Synthetic - genetics | Vaccines, Subunit - immunology | Birnaviridae Infections - veterinary | Fish Diseases - prevention & control | Viral Vaccines - administration & dosage | Infectious pancreatic necrosis virus - immunology | Vaccines, Inactivated - immunology | Animals | Fish Diseases - virology | Pseudomonas aeruginosa - genetics | Vaccines, Inactivated - administration & dosage | Escherichia coli - genetics | Vaccines, Subunit - administration & dosage | Survival Analysis | Nanoparticles - administration & dosage | Vaccines, Synthetic - administration & dosage | Viral Vaccines - immunology | Virus diseases | Antigens | Salmon | Analysis | Universities and colleges | Vaccines | Comparative analysis | Health aspects | Studies | Proteins | Nanoparticles | Fish | Viruses | Infections | Deoxyribonucleic acid--DNA
Journal Article
Vaccine, ISSN 0264-410X, 2014, Volume 32, Issue 19, pp. 2251 - 2259
Journal Article
Vaccine, ISSN 0264-410X, 07/2018, Volume 36, Issue 29, pp. 4278 - 4286
Journal Article